SETRUSUMAB
UNII FPW3780T3E

Substance Identification & Data

This profile provides standardized clinical and technical data for Setrusumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FPW3780T3E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1847394-95-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FPW3780T3E

CAS Registry Number

1847394-95-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SETRUSUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152352

National Cancer Institute reference terminology for clinical and research data.

INN ID

10539

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-63

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Setrusumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SETRUSUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G2, ANTI-(HUMAN SCLEROSTIN) (HUMAN MONOCLONAL BPS804 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BPS804 LIGHT CHAIN, DIMER

IMMUNOGLOBULIN G2-LAMBDA, ANTI-(HOMO SAPIENS SOST (SCLEROSTIN)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA2 HEAVY CHAIN (1-443) (HOMO SAPIENS VH (IGHV3-66*01 (89.80%) -(IGHD) -IGHJ4*01) (8.8.10) (1-117) -IGHG2*01, G2M.. (CH1 (118-215), HINGE (216-227), CH2 V45.1 (278) (228-336), CH3 (337-441), CHS (442-443)) (118-443)), (131-216')-DISULFIDE WITH LAMBDA LIGHT CHAIN (1'-217') (HOMO SAPIENS V-LAMBDA (IGLV2-23*02 (92.60%) -IGLJ2*01) (9.3.11) (1'-111') -IGLC2*01 (112'-217')); DIMER (219-219'':220-220'':223-223'':226-226'')-TETRAKISDISULFIDE

SETRUSUMAB [INN]

SETRUSUMAB [USAN]

SETRUSUMAB [WHO-DD]